Trial Profile
The efficacy of dabigatran for portal vein thrombosis/Budd-Chiari syndrome
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 Oct 2014
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Budd-Chiari syndrome
- Focus Therapeutic Use
- 18 Oct 2014 New trial record